The Infectious Diseases Society of America (IDSA) read a statement before the House Committee on Energy and Commerce’s Subcommittee on Health today entitled, “Promoting Anti-Infective Development and Antimicrobial Stewardship through the U.S. Food and Drug Administration Prescription Drug User Fee Act…

FDA has announced a 2-day public hearing to obtain input on its regulatory oversight of clinical research. The target audience includes industry representatives, investigators, IRBs, professional organizations, advocacy groups, and others involved with clinical trials. Advance registration is required to attend…

The Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA) are both up for congressional re-authorization this year. On February 29, 2012, the Institute of Medicine released a study committee report examining these and other pieces of…

The American Biological Safety Association (ABSA) is offering a webinar entitled, “Selecting the Right Decontamination Agents for Facility and Equipment Decontamination” on April 5, 2012 from 1:30 – 3:30pm (CST).  Registration information and a brochure is available here.  This webinar

The USDA’s Animal and Plant Health Inspection Service (APHIS) is seeking feedback on programs and services.  A link is available on the APHIS Stakeholders webpage for taking a survey requesting information on its most valuable activities and ways to enhance partnerships and

A notice has been filed in the Federal Register announcing a public hearing on the topic of the National Emerging Infectious Diseases Laboratories (NEIDL).  The  meeting will take place on Thursday, April 19, 2012, from 6:30 p.m. to 9:30 p.m. at